Part 1 of banner
Part 2 of banner
Part 3 of banner
Part 4 of banner
Part 5 of banner

ABOUT US > Company profile

Biocellvia is a pioneer in compound validation assay development.
« Our technology is the guarantee of the same accuracy and reliability all along your research proceedings. »
Yvon JULE, co-founder and CSO

BASED ON DIGITAL IMAGING ANALYSIS OF TISSUES

While histological image analysis still currently uses the scoring method to evaluate morphological changes in tissues, Biocellvia’s investigations have been based on automated micro-computed imaging analysis.

  • A technology giving access to a more accurate, sensitive and reliable assessment of the efficacy of candidate molecules.
    >> Biocellvia’s technology <<
  • Tailor-made assays: each study is developed according to the research project and the standards of our clients.
    >> tailor-made assays <<

FOR A CLEARER DECISION-MAKING IN COMPOUND EVALUATION

Biocellvia’s digital imaging technology provides robust investigative tools for preclinical research with:

  • Fully automated analysis processings allowing a very fast assessment of the efficacy of compounds.
  • Accurate and reproducible data, which allow to make an informed decision regarding the next steps of the research project.

DEDICATED TO PRECLINICAL RESEARCH

Biocellvia’s imaging technology is currently applied to in vitro and ex vivo models to evaluate the efficacy of active compounds on various pathologies.  >> pathologies <<

KEY FIGURES

1 technology 100% dedicated to preclinical research
Since 2013, 20,000 samples analyzed
Used in more than 6 countries
>15 years experience
100% reproducible
FREE TRIAL